The similarity of the catalytic domains of Raf and Src family members suggests that functions of homologous residues may be similar in both kinase families. A tryptophan residue, W260, in the WEI region of the Src family kinase Hck has an important role in regulating ATP binding. We tested the hypothesis that the tryptophan, W342, in the WEI region of c-Raf may have a similar role to the W260 of Hck. Mutation of W260 to A in Hck activates kinase activity, but we found that mutation of W342 to A in c-Raf inactivates the kinase activity. Mutating W342 to aspartate (D), lysine (K) or histidine (H) also inactivated c-Raf whether assayed as a puri®ed immunoprecipitate or when recruited to the plasma membrane. A constitutively active c-Raf can be generated by mutating two regulatory tyrosines to aspartate. When placed into this active c-Raf mutant, mutation of W342 to D, K or H enabled phosphorylation and activation of the c-Raf substrate MEK at the plasma membrane but not in an immunoprecipitation assay. We conclude that (1) Tryptophan has a dierent role in the WEI regions of c-Raf and Hck, (2) W342 is not directly involved in MEK binding as both positive and negative residues at 342 are permissive for MEK activation at the membrane in a constitutively active c-Raf mutant, (3) Factors at the membrane are capable of potentiating activation of c-Raf containing mutated W342 in a hyperactivated c-Raf, but not in a wild type c-Raf and (4) There is a stringent structural requirement for W at residue 342 in c-Raf.
Introduction
There is a signi®cant sequence homology between the Raf serine/threonine protein kinase family and the Src tyrosine protein kinase family members (Mark and Rapp, 1984) . In fact, based on homology of the catalytic C-terminal domains, early reports suggested that Raf and Src were members of the same protein evolutionary family tree (Mark and Rapp, 1984) . While the structure of some Src family members has been solved (Sicheri et al., 1997) , the majority of the structure of the c-Raf remains unknown. In particular a critical tryptophan, W260, in the DAWEI motif of the Src family member, Hck, serves a negative regulatory role (LaFevre-Bernt et al., 1998) . The W260 in the WEI sequence of Hck binds to an alpha helix above the activation loop. On activation, a global conformational change in Hck allows the W260 to rotate allowing movement of the alpha helix and so increasing the anity of the ATP binding site. Morrison and colleagues (Cutler et al., 1998 ) have suggested a model where c-Raf undergoes a similar global conformational change, allowing removal of a negative regulatory domain. The sequence homology around the regulatory WEI sequence (Figure 1 ) of the two kinases suggests the function of this tryptophan in c-Raf might be the same. In this study we have examined the role of the W in the WEI region of c-Raf and found it has a dierent role to the W in the WEI region of the Src-family member, Hck.
C-Raf is a 74 kDa serine/threonine kinase that initiates the Mitogen Activated Protein Kinase (MAPK) cascade (reviewed in Campbell et al., 1998) . The MAPK cascade is central to many cellular functions, including growth, cell cycle and apoptosis and there is an extensive eort to understand the regulation of the components of this pathway. While we have a fair understanding of the regulation of downstream components of the pathway, MAPK Kinase (MEK) and MAPK, the complex regulation of the c-Raf kinase remains to be resolved.
When an external growth factor binds to and activates a receptor tyrosine kinase, adaptor proteins are recruited to the cytoplasmic domain of the receptor. The adaptor complexes, some having Ras Guanine Nucleotide Exchange Factor (GEF) activity, catalyze the formation of active Ras-GTP from inactive Ras-GDP at the inner face of the plasma membrane. Active Ras-GTP recruits several important signal transduction molecules to the plasma membrane from the cytoplasm, including Phosphatidyl Inositol-3-Kinase, AF-6, RalGDS and c-Raf (Campbell et al., 1998) . C-Raf is then activated by a process we only incompletely understand. Activated Raf then phosphorylates and activates MEK which phosphorylates and activates MAPK which has several targets including Elk-1 and Rsk family members.
C-Raf may be regulated in vitro by several mechanisms, including the addition of phospholipid (McPherson et al., 1999; Rizzo et al., 1999) , phosphorylation (King et al., 1998; Xia et al., 1999) and dephosphorylation (Dent et al., 1995 (Dent et al., , 1997 Xia et al., 1999) . A critical regulatory region of c-Raf is residues 338-341 (SSYY). Mutation of the two tyrosines, 340/1, to aspartic acid results in constitutive activation of cRaf while mutation of the same residues to phenylalanine does not allow activation (Fabian et al., 1993; Roy et al., 1997) . Morrison and co-workers (Cutler et al., 1998) have suggested that the tyrosines help the negative regulatory N-terminal domain to bind to the C-terminal catalytic domain and that the YY/DD mutation mimics the tyrosine phosphorylation that has been observed on activation (Jelinek et al., 1996; Xia et al., 1999) . In this hypothesis, phosphorylation of tyrosine would repulse the two domains from each other, freeing the catalytic domain to bind and activate MEK. Further detailed mutagenesis studies have shown that the residues essential for c-Raf activity in this region are S338 and Y341 (Mason et al., 1999) .
The residues immediately C-terminal to the SSYY are WEI. The WEI sequence also appears in Src family members (Figure 1) where it has an important regulatory function (LaFevre-Bernt et al., 1998) . The W260A mutant of the Src family member, Hck, has a higher speci®c activity than wild type and this is due to a release of constraints on the activation loop, allowing it to complex ATP (LaFevre-Bernt et al., 1998). Here we have examined the function of the W342 residue in c-Raf and have found that it has a very dierent function to the analogous residue in Src family members.
Results
The 342 W/A mutation does not activate c-Raf
Mutations in the critical tryptophan, W260, of the sequence WEI of Hck signi®cantly potentiate Hck kinase activity (LaFevre-Bernt et al., 1998) . Since nothing is known about the eects of W substitutions in c-Raf in the homologous region around WEI, next to the important regulatory residues, S338 and Y341 (Figure 1 ), we mutated W342 of c-Raf to A to see if the mutation brought about the same change in kinase activity as in Hck. Rather than the expected increase in kinase activity we observed this c-Raf mutant had negligible kinase activity in an immunoprecipitation (IP) assay (Figure 2a ). Previously we had measured the kinase activity of the c-Raf zinc ®nger mutant, CC/SS 165/168 and found that loss of kinase activity may be due to loss of the accessory protein, 14 3 3 (McPherson et al., 1999) . Unlike the CC/SS mutant, the W/A342 mutant had no dierence in 14 3 3 binding compared to wild type c-Raf (Figure 3a) , suggesting the loss of kinase activity in the W/A342 mutant was not due to altered 14 3 3 binding. C-Src, Akt and certain Protein Kinase C (PKC) isoforms are also possible in vivo regulators of Raf function (Marais et al., 1998; Stokoe and McCormick, 1997; Ueda et al., 1996; Zimmermann and Moelling, 1999) . We found that the co-precipitation of c-Src and novel PKC isoforms z or i with c-Raf was not altered by mutation of W342 (Figure 3a) . We could not detect conventional PKC isoforms a, b or g or Akt in immunoprecipitates of c-Raf prepared by our method (Figure 3a legend) .
We then measured the activity of the W/A342 mutant when recruited to the membrane by active HRasV12. RasV12 is constitutively in the active GTP form and readily recruits wild type c-Raf to the plasma membrane where it can be activated by unknown mechanisms (Campbell et al., 1998) . The W/A342 mutant was recruited by H-Ras (Figure 2b ), an expected result as the Ras binding motifs of Raf are around residues R89 and CC165/168, far from W342 in primary sequence (Campbell et al., 1998) . While recruitment by H-Ras robustly activated wild type cRaf kinase activity, there was no activation of W/A342 at the membrane under identical conditions nor was there any activity of the W/A mutant in the cytosolic S100 fraction (Figure 2c ). The W342 to A mutation in c-Raf creates a kinase that is either not able to bind to substrate or unable to phosphorylate bound substrate.
Mutation of W342 to a positive or negative charge also abrogates activity
To further investigate the function of this residue, we made several other mutations of and around W342. W342 was mutated to positively charged lysine (K), a negatively charged aspartate (D) and a histidine (H) which is perhaps the closest amino acid in structure and properties to tryptophan. Mutation of W342 to D, H or K generated a kinase with similar properties to the W/A342 mutant, they were not active as immunoprecipitates (Figure 3b ), in a cytosolic S100 fraction or when recruited to the membrane by H-Ras (Figure 4a , b). Like the W/A342 mutant, none of these W342 mutations had any eect on 14 3 3, c-Src or z or i PKC isoform binding when compared to wild type cRaf (Figure 3a ).
Creation of W342 mutants in a hyperactive background
Because of the low kinase activity in all the W342 mutants, we created W342 mutants in a mutationally activated c-Raf. The YY/DD340/341 mutation in c-Raf creates an activated kinase, possibly due to the negative charges of aspartate mimicking phosphorylation of tyrosine that may occur on activation (Jelinek et al., 1996; Xia et al., 1999) . The hyperactivated background should make it easier to measure the kinase activity of mutants with very low basal activity. While the DDH and DDK mutants had no activity in an IP assay, the DDD mutant had about the same activity as wild type c-Raf (Figure 3b) .
When recruited by H-RasV12 to the membrane (Figure 4a ), the DDD, DDH and DDK mutants are all capable of phosphorylating and activating MEK ( Figure  4c ), albeit to a lesser extent than the DD mutant. This is in marked contrast to the activity in the cytosolic S100 fraction (Figure 4c ), the IP experiments above ( Figure  3b ) and the experiments conducted in the absence of the DD mutation (Figure 4b ). We further con®rmed this data by measuring the increase in kinase activity of c-Raf Figure 1 Sequence alignment of partial sequence of c-Src (Accession P12931) and c-Raf (Accession P04049) around the W260 of Hck and W342 of c-Raf (W in bold type) generated using LALIGN IP'd from cells treated with EGF. EGF activates several growth factor pathways, including the Ras-mediated pathways (Moghal and Sternberg, 1999) . Surprisingly we found that both wild type Raf and Raf 342 W/D IP's were signi®cantly activated by EGF treatment ( Figure 5 ) despite there being no activation of RafW/D by HRasV12 at the membrane (Figure 4b ). This implies that c-Raf 342 W/D may be a useful tool for investigating non-Ras mediated mechanisms of activating c-Raf (Moghal and Sternberg, 1999; Ueda et al., 1996; Ziogas et al., 1998) . The IP's from the cells expressing the DDD, DDH and DDK mutants were all activated about twofold by EGF, while the DD mutant was not ( Figure  5 ). This twofold activation may re¯ect removal away from inhibiting factors at the membrane after immunoprecipitation or partial activation made possible by the DD background.
Mutation of W342 does not affect MEK binding
If W342 were interacting with the c-Raf substrate, MEK, then either a positive or a negative charge at 342 in c-Raf, but not both, would be capable of interacting with complementary charged residues on MEK. We hypothesize that W342 is not involved in substrate MEK binding. To con®rm this hypothesis, we measured the binding of puri®ed MEK to c-Raf immunoprecipitates. We tested the ability of all the above W342 mutants to bind the c-Raf substrate, MEK-1. The 342 W/A, W/D, W/H and W/K mutants all bound MEK about the same as wild type c-Raf (Figure 6a, b) , suggesting that W342 is not involved in binding to MEK. We also found that the mutants in a DD background appeared to bind between 2.5 and ®vefold more MEK than wild type c-Raf. However we found that the relative amount of MEK binding to the mutants in a DD background was highly variable and so it is dicult to draw precise quantitative conclusions (Figure 6b ). It is tempting to speculate that this data provides a partial explanation for the higher kinase activities observed for c-Raf DD (Figure 3b ).
Detailed sequence analysis of WEI-containing kinases
Our experimental results show that the W in the WEI region has a dierent role in c-Raf and Hck. Therefore we re-examined the sequence homology in the WEI region of both Src and Raf kinase families by searching the online Prosite database (http://www.expasy.ch/ prosite/; 81 263 entries). We searched for the YYWEI sequence of c-Raf ®rst and found it only occurred in the c-Raf/Mil family of proteins. An active isoform of c-Raf, . The P100 membrane (P) and S100 cytosolic (S) fractions were assayed as described in Materials and methods. Shown are representative Western blots for FLAG antibody (Raf), Ras and Active ERK. (c) Cytosolic (S) and membrane (P) Speci®c Kinase Activities (Active ERK Units/FLAG Units) for wild Raf (WT) and Raf W/A in the presence of oncogenic RasV12. The data was normalized relative to wild type Raf at the plasma membrane with an activity of 1. Shown are the means and standard deviations of two separate experiments B-Raf has the sequence DDWEI and the mutation of YYWEI to DDWEI in c-Raf hyperactivates kinase activity (Figure 3b ), mimicking the probable phosphorylation of tyrosine observed on c-Raf activation (Jelinek et al., 1996; Stokoe and McCormick, 1997) . In particular a negative charge on the second Y is important, the ®rst Y is non-essential for activity (Mason et al., 1999) . In Src family members, the sequence DAWEI appears, with Hck being a good example (LaFevre-Bernt et al., 1998). We searched the ProSite database (http://www.expasy.ch/prosite/) for the sequence XXWEI. We limited our search to proteins where either X is a negative charge, based on the common motifs in the Src and Raf families and to keep the search manageable. The proteins were then classi®ed as a kinase or non-kinase and the results analysed after discarding hypothetical proteins.
Among kinases with a negative charge at the ®rst position in XXWEI, there is a ®vefold preference for D over E (Figure 7a ). There is no preference for either a D or an E for like proteins classi®ed as non-kinases. We also noted a strong bias towards an A in the second position in kinases with a negative charge at the ®rst position. Detailed examination of the database revealed that most kinases with the sequence DAWEI Figure 2c ) of FLAGRaf W/ X mutants in the cytosol (S) and membrane (P) fractions in the presence of RasV12. The data was normalized to wild type Raf in the P fraction=1. Shown are the means and standard deviations of four separate experiments. (c) Speci®c Kinase Activity (see Figure 2c ) of FLAGRaf DDW/X mutants in the cytosol (S) and membrane (P) fractions in the presence of RasV12. The data was normalized to wild type Raf in the P fraction=1 (Figure 4b) . Shown are the means and standard deviations of two separate experiments were members of the Src family where this sequence is recognized as a homology sequence. Among kinases with a negative charge at the second position of XXWEI, we surprisingly found that they all had a negative charge at the ®rst position as well (Figure 7b ) with no clear preference seen in non-kinases with a negative charge in the second position of XXWEI. In summary, in kinases with the sequence XXWEI, where either X is a negative charge, there is an absolute requirement for a negative charge in the ®rst position only. This is in clear contrast to c-Raf which probably requires a negative charge on the second tyrosine for activity (Mason et al., 1999) . So c-Raf diers from the Src family member, Hck, in three ways, ®rst the W in the WEI sequence has a dierent function, second it is unique in having the sequence YYWEI in a critical regulatory region and third it probably requires a negative charge on the second residue in the XXWEI sequence for activity where Hck has a negative charge on the ®rst residue.
Discussion
Here we show that the homology between Raf and Src family members in the critical SSYYWEI sequence is not a functional homology as the W appears to have a dierent role. This study presents the ®rst detailed examination of this residue in c-Raf and we show that it does not regulate binding of c-Raf upstream aectors H-Ras, c-Src and z or i PKC isoforms or the downstream substrate, MEK-1. The 14 3 3 protein, which has an important function in regulating c-Raf activity (Roy et al., 1998) , also is not aected by mutating W342. Recently, the kinase Akt has been shown to be a putative negative regulator of c-Raf kinase activity (Zimmermann and Moelling, 1999 ) but we could not detect Akt bound to c-Raf under our experimental conditions. Another possible aector of cRaf is PAK-3, which phosphorylates S338 (King et al., 1998) and this may be aected by mutation of W342. Although we observed that binding of c-Src, which probably phosphorylates Y341 (Mason et al., 1999), was not altered by mutation of W342. The W342D mutant is also important in mediating EGF activation of c-Raf that does not go through a H-Ras pathway. The Ras to Raf to MEK to MAPK pathway has been thought to be a simple linear pathway. Recently, COT1 has been shown to activate MEK (Hagemann et al., 1999) , TC21 has been shown to activate Raf (Rosario et al., 1999) , MKP-1 regulates c-Raf and MAPK (Shapiro and Ahn, 1998) . Clearly there are`branches' in the pathway and it may be that other molecules may also participate in the MAPK cascade in ways that have not been observed to date.
Activation of the DDD, DDH and DDK mutants at the membrane, but not as immunoprecipitates, demonstrates that unidenti®ed factors in the membrane environment allow activation of c-Raf with a W342 mutation in the presence of the activating DD mutation. This eect could simply be enzyme stabilization in a membrane based complex. The DD mutation would be preferentially stabilized in such a complex as the W mutants lacking the DD are not able to be activated at the membrane. The DD mutants all bind higher levels of MEK than wild type c-Raf without any signi®cant dierence in MEK binding between dierent W mutants. The W residue does not in¯uence substrate MEK binding. The enhanced binding of MEK to the DD mutants might be explained by an increased anity of existing MEK binding sites or exposure of extra binding sites as the c-Raf changes conformation on introduction of negative charges at YY340/341.
Our data demonstrate a stringent structural requirement for a tryptophan in position 342 of c-Raf. The residue does not contribute to binding of several known co-factors or substrate. We hypothesize that W342 regulates kinase activity in a positive manner. The W260 of Hck appears to have a negative in¯uence on intrinsic kinase activity. Our analysis of the sequence homology between Src and Raf family members further demonstrates the fundamental charge dierences between the two families around the critical XXWEI regulatory region. Therefore we conclude that the function of W in the homology XXWEI region of Src and Raf family members is dierent and so the two family members might also have dierent modes of regulation. A corollary of this is that the structure of Src family members might not be a good model for those of Raf family members and the structure of Raf will have to be determined de-novo.
Materials and methods

Plasmid mutagenesis and COS1 cell transfections
The EXV FLAGRafW/A342 plasmid and other plasmids with mutations in 340, 341 and 342 were made by the same PCR-based strategy used for making EXVFLAGRafDD (Roy et al., 1997) . The mutant Raf was sequenced and found identical to wild type except for the desired mutation. COS1 cells were electroporated exactly as described (Roy et al., 1997) . After 48 h, the cells were changed to serum free media. After an additional 24 h, the cells were harvested into PBS and the pellets stored at 7708C.
Immunoprecipitations and kinase assays
Immunoprecipitations with anti-FLAG beads and kinase assays were performed exactly as described (McPherson et al., 1999) . Brie¯y IP's were incubated with MEK (0.25 mg) and ERK (1 mg) in MgATP buer for 20 min at 308C at 1400 r.p.m. in an Eppendorf Thermomixer (Roy et al., 1997) . SDS ± PAGE loading buer was added to the tube and the samples loaded onto 15% SDS ± PAGE gels, transferred to PVDF and probed with anti-Raf antibody (Santa Cruz C20), stripped and reprobed with a polyclonal anti-active ERK antibody (Quality Controlled Biologicals) both developed using chemiluminescence (Amersham ECL) all according to manufacturers instructions. The resulting X-Ray ®lms were scanned into a computer and densitometrically analysed using the Gel Plotting Macro provided in the free NIH Image software. Data is presented as Speci®c Kinase Activity which is the number of Active Kinase units divided by the number of Raf units after subtraction of untransfected COS1 cell background. The data was then normalized relative to wild type Raf=1.
For EGF treated cells, cells were incubated with 10 ng/ml EGF in serum free media containing 1% BSA for 5 min at 378C and harvested immediately into ice cold PBS and stored at 7708C. The Raf kinase activities were measured as above. After subtraction of untransfected COS1 cell background, the data was expressed as Fold Activation=Speci®c Kinase Activity After EGF/Speci®c Kinase Activity Before EGF.
For MEK binding assays, the IP's were incubated with 3 mg MEK-1, incubated for 20 min at 308C at 1400 r.p.m. The samples were then washed twice with IP buer and the samples ran on 15% SDS ± PAGE gels and transferred to PVDF. The PVDF was probed with anti-FLAG (M2, Kodak/IBI) and anti-MEK antibodies (Santa Cruz MEK-1 (12-B) ) and the ®lms densitometrically scanned as above. After subtraction of untransfected COS1 background, data was expressed as MEK Units/FLAG Units.
Membrane kinase assays
COS1 cells were transfected with EXVFLAGRaf and EXVHRasV12 (a generous gift of John Hancock) as described above (Roy et al., 1997) . The cells were harvested into lysis buer and the membrane P100 and cytosolic S100 fractions were prepared, the protein content measured and aliquots stored at 7708C (Roy et al., 1997) . Upon thawing, protein amounts were equalized between samples and the volume made up to the same with lysis buer. The samples were incubated in MgATP buer with MEK and ERK as described (Roy et al., 1997) . After an incubation for 20 min at 308C, the reactions were terminated by placing on ice and the samples ran on 15% SDS ± PAGE gels and transferred to PVDF. The PVDF membranes were probed with anti-FLAG (Raf), anti-Ras259 (ATCC hybridoma supernatant) and polyclonal anti-active ERK (Quality Controlled Biologicals) and the chemiluminescence on the anti-FLAG blot was developed with Super Signal WestDura (Pierce). The resulting ®lms were densitometrically scanned as above. After subtraction of untransfected COS1 backgrounds from FLAG data and Ras alone backgrounds from Active ERK data, the activity was expressed as Speci®c Kinase Units as above.
